A System Biology-Based Approach for Designing Combination Therapy in Cancer Precision Medicine

Table 5

Quantitative comparison of the results of BC group therapies, where and age are therapy agents.

Individual characteristics	Dose value	H	M	L
,	H; 9	,,
	M; 4
	L; 1

First column: two considered personalize characteristics. Second column: dose value for controlling first characteristic. First row: normalized dose values for controlling 2nd characteristic.